Counselors in Manning, IA Accepting Medicare
4 Counselors found. Showing 1 - 4
 Emmalee Esther Bolin, LBSW, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1550 6th St, Manning, IA 51455 Phone: 712-655-8353 Fax: 712-655-8241 |
Jennifer Masching, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1550 6th St, Manning, IA 51455 Phone: 712-655-8107 |
 Damon Allen Bromley, TCADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1550 6th St, Manning, IA 51455 Phone: 712-655-8118 |
Amy Blackwell Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1550 6th St, Manning, IA 51455 Phone: 712-655-2300 |
News Archive
European Commission approves BMY's ONGLYZA to treat type 2 diabetes
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
UCLA receives $5M from NIH to develop tool for detecting stomach cancer
Imagine having a sample of your saliva taken at the dentist's office, and then learning within minutes whether your risk for stomach cancer is higher than normal. That futuristic-sounding scenario may actually not be too far from reality.
Mammalian cells divide when their growth rate hits a specific threshold
It's a longstanding question in biology: How do cells know when to progress through the cell cycle? In simple organisms such as yeast, cells divide once they reach a specific size. However, determining if this holds true for mammalian cells has been difficult, in part because there has been no good way to measure mammalian cell growth over time.
Congressman Fattah lends full support to The Pancreatic Cancer Research and Education Act
"Pancreatic cancer is a rare and perplexing disease, yet it is the fourth leading cause of death by cancer in the United States. This year, more than 42,000 Americans will be diagnosed with the disease and more than 35,000 will die from it. That number is far too high.
Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients
Doctors have found that treating prostate cancer with a single, high dose of radiation delivered precisely to the site of the tumor results in good quality of life and fewer trips to the hospital, with adverse side effects that are no worse than if the radiation treatment had been given in several lower doses.
› Verified 2 days ago